Back to search

Article

Recurrence of neovascular age-related macular degeneration after cessation of treat-and-extend regimen

2022-07-12

Abstract excerpt

The appropriate timing of treatment cessation after treat and extend (TAE) regimen for age-related macular degeneration has not been established. This study aimed to investigate the incidence and risk factors of recurrence after cessation of the TAE regimen. We included patients who received and discontinued the TAE regimen, after extension of the treatment interval to > 12 weeks. The total number of injections, t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0e4c5e88-3c1e-563c-9122-96d69fbf4f7e
DOI
10.21203/rs.3.rs-1814574/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Recurrence of neovascular age-related macular degeneration after cessation of treat-and-extend regimenDOI 10.21203/rs.3.rs-1814574/v1
Factors Associated with Recurrence of Age-Related Macular Degeneration after Anti-Vascular Endothelial Growth Factor Treatment: A Retrospective Cohort Study.Semantic proximity
Qualitative analysis by OCTA in patients with choroidal neovascularization secondary to angioid streaks as predictors of disease recurrences over timeSemantic proximity
The Moorfields AMD Database Report 2 - Fellow Eye Involvement with Neovascular Age-related Macular DegenerationSemantic proximity
Removal of scleral buckle: indications, long-term outcomes and comparison with the literatureSemantic proximity
Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathySemantic proximity
Eighteen-Month Real-World Outcomes of Intravitreal Aflibercept 8 mg in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A UK Single- Centre ExperienceSemantic proximity
Sequential switch from first-line anti-VEGF therapy to faricimab and subsequent aflibercept 8mg in treatment-resistant neovascular AMDSemantic proximity
Short-Term Efficacy of Aflibercept 8 mg in Refractory Neovascular Age-Related Macular Degeneration: A Real-World Retrospective Case Series from TaiwanSemantic proximity
Result of Intravitreal Aflibercept Injection for Myopic Choroidal NeovascularizationSemantic proximity
Response of OCT Biomarkers Based on New Diabetic Macular Edema Classification TCED-HFV to Anti-VEGF Therapy and Its Prognostic Role in Vision BenefitsSemantic proximity
Foveal Serous Retinal Detachment with Inferior Staphyloma: Long-Term Treatment Response to Anti-VEGF and Photodynamic TherapySemantic proximity
Risk Factors for Developing Neovascular Glaucoma in Central Retinal Vein Occlusion: a 2-year Longitudinal Real-World StudySemantic proximity
Select a neighboring publication to make it the new centre.